Navigation Links
ORNL, St. Jude track neurons to predict and prevent disease
Date:3/30/2009

Researchers at the Department of Energy's Oak Ridge National Laboratory and St. Jude Children's Research Hospital are looking at how developing nerve cells may hold a key to predicting and preventing diseases like cancer and Alzheimer's and Parkinson's disease.

St. Jude scientists have linked movement and changes of nerve cells, or neurons, in the brains and retinas of young mice to certain diseases. Now, for the first time, they can use ORNL-developed software to analyze these vast amounts of data in record time.

"St. Jude has identified neuron shape abnormalities and neuron migration issues that are linked to specific diseases," said Shaun Gleason of ORNL's Measurement Science and Systems Engineering Division. "However, because they have so much data, they can't study it in great detail."

Gleason said ORNL is working with Michael Dyer of St. Jude's Department of Developmental Neurobiology to develop computer software that will automate the process of tracking changes in the shape and position of neurons over time.

One of Gleason's group members, Ryan Kerekes, already has written software to track the movement of neurons by homing in on each cell's centrosomea key cellular structure. This will enable the software to scour a sequence of video images at high speed, looking for specific patterns of migration, Gleason said.

"For example, a member of the St. Jude staff took several weeks to analyze the image data generated by three experiments using a largely manual approach," Gleason said. "Our algorithm can analyze the same data set in approximately two minutes with almost identical results.

"When St. Jude researchers analyze their images, they look for several specific changes, but there may be much more relevant information in those images that they don't have the ability to look for. Our software is designed to help them find this information in a more efficient and objective manner, so they can understand
'/>"/>

Contact: Jim Pearce
pearcejw@ornl.gov
865-241-2427
DOE/Oak Ridge National Laboratory
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. ORNL, Southern Cal set sights on preventing blindness
2. New tracking tags are providing fish-eye views of ways to manage depressed fisheries
3. Tracking tigers in 3-D
4. ESAs water mission on track for launch
5. Animal trackers collaborate on new Google Earth for oceans
6. Tracking poultry litter phosphorus: Threat of accumulation?
7. Tracking the molecular pathway to mixed-lineage leukemia
8. VUANCE Announces Crime Scene Security and Evidentiary Tracking Development Project
9. Studies on imaging and tracking transplanted cells
10. UNH researchers track lobster migrations to improve population estimates
11. Track your fitness, environmental impact with new cell phone applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 1Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 2Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 3Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 4Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 1Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 2Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 3Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 1Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 2Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 3
...known as HACNS1, that may have contributed to the ...nd possibly also modifications in the ankle or foo... to a paper published in Science on Sept. 5, 200...of the existence of human-specific gene enhancers,.... , Dr. Shyam Prabhakar, first author of the pa...
...f Cincinnati (UC) implicates the primary chemical ... risk factor for metabolic syndrome and its conseq...n fat tissues, the UC team found that BPA suppress...e for regulating insulin sensitivity in the body a...metabolic syndrome. , Metabolic syndrome is a co...
... A variety of organismsfrom bacteria and fungi to ...he timing and duration of fundamental biological p...apt and survive, even under fluctuating environmen...nces have been made to understand the molecular ba...odifications in cellular physiology and organismal...
Other Biology News:Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Bisphenol A linked to metabolic syndrome in human tissue 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2
... BOTHELL, WA, and VANCOUVER, April 9 /PRNewswire-F...Genex" or the "Company") (NASDAQ: OGXI ), announ...ences Company of the Year by LifeSciences British ...iences British Columbia to recognize a local organ... the development of British Columbia,s life scienc...
... BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac...oper and provider of vaccines in China, today anno...r the three and twelve month,periods ended Decembe...ghts, -- Record full year 2008 sales increasing... Sold 6.93 million doses of Healive(R) in 2008, up...
... , , , Company Reports Quarterly Net Income of...International, Inc. (OTC Bulletin Board: CCEL) (t... established family cord blood banks, today announ...8, 2009. Consolidated revenues for the first quar... compared to approximately $4.2 million for the fi...
Other Biology Technology:OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 2OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 13Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 14Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 15Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 16Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 17Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 18Cryo-Cell International, Inc. Reports First Quarter 2009 Results 2Cryo-Cell International, Inc. Reports First Quarter 2009 Results 3Cryo-Cell International, Inc. Reports First Quarter 2009 Results 4
Goat Anti-HSPC150 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human Oct 2 Monoclonal Antibody, Unconjugated, Clone PT2 from ABR-Affinity BioReagents
Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam
Mouse Anti-Aequorin Monoclonal Antibody, Unconjugated, Clone 2Q2147 from Abcam
Biology Products: